Home » Newsletters » BioWorld Science

BioWorld Science

April 3, 2014

View Archived Issues

Clinical data presented on sofosbuvir/ledipasvir fixed-dose combination for HCV

GlycoVaxyn designs new bioconjugates

Novel GPR119 agonists developed by Boehringer Ingelheim and Neurocrine Biosciences

Sanofi and Regeneron report data from phase II Japanese study of alirocumab

AstraZeneca and Medical Research Council establish collaboration

Almirall acquires European rights to InDex's ulcerative colitis drug candidate

New nAChR PAMs reported by Dainippon Sumitomo Pharma

FORMA Therapeutics and Celgene form multi-year strategic alliance

Astellas Pharma establishes regenerative medicine unit

Living Cell Technologies completes restructuring

New OPEN initiative aims to reinforce importance of biomarker testing in mCRC

Research agreement aims to identify biomarkers for SLE and lupus nephritis

Evotec and Convergence form alliance to discover novel analgesics

Evotec and Debiopharm collaborate in oncology drug discovery and development

Medesis Pharma and CEA sign collaborative agreement

Venaxis seeks FDA clearance of APPY1 Test for appendicitis

Cyclenium Pharma begins laboratory operations at the NEOMED Institute

Novel MPS1 inhibitors patented by Cancer Research Technology

Glenmark Pharmaceuticals discloses new ITK inhibitors

Array BioPharma and Amgen present novel glucokinase activator with improved profile

Immunovaccine and Pfenex report data from single-dose anthrax vaccine studies

Creabilis presents phase IIb data for CT-327 in psoriatic patients with chronic pruritus

ReGenX Biosciences and Avexis enter into agreement for NAV rAAV9 vectors

FDA grants fast track designation to Tetraphase Pharmaceuticals' eravacycline

Phase II results show safety and efficacy of VM-202 intramuscular injections in patients with CLI

EMA validates Keryx Biopharmaceuticals' MAA for Zerenex

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...